These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3462649)

  • 1. [Experimental treatment of acute renal insufficiency with prostaglandin E2].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Patol Fiziol Eksp Ter; 1986; (3):67-9. PubMed ID: 3462649
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic criteria of the effective treatment of acute renal failure with prostaglandin E2].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Anesteziol Reanimatol; 1985; (1):34-6. PubMed ID: 3857873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental prostaglandin E2 therapy of acute kidney failure due to the crush syndrome].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Biull Eksp Biol Med; 1984 Nov; 98(11):532-3. PubMed ID: 6595032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental therapy of acute kidney failure with prostenon, a Soviet prostaglandin E2].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Kushch IO; Kotsaĭ LV
    Biull Eksp Biol Med; 1983 May; 95(5):28-9. PubMed ID: 6573928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of long-term prostaglandin E2 infusion on the course of postischemic acute renal failure. Long-term studies in chronically instrumented conscious dogs.
    Neumayer HH; Wagner K; Groll J; Schudrowitsch L; Schultze G; Molzahn M
    Ren Physiol; 1985; 8(3):159-68. PubMed ID: 3895330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on some effects of prostaglandin E2 in acute renal failure.
    Mitra K; De MK
    J Indian Med Assoc; 1990 Jan; 88(1):10-3. PubMed ID: 2362130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased renal prostaglandin E2 metabolism: a mechanism for the regulation of prostaglandin activity in acute renal failure.
    Chaudhari A; Kirschenbaum MA
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():543-6. PubMed ID: 6221577
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of cyclosporine nephrotoxicity by prostaglandin E2 after experimental renal transplantation.
    Pomer S; Röhl L; Hull W; Behringer J; Schmidt-Gayk H
    Transplant Proc; 1987 Oct; 19(5):4041-2. PubMed ID: 3313994
    [No Abstract]   [Full Text] [Related]  

  • 9. Protective effect of prostaglandin E1 on ischemia-induced acute renal failure in dogs.
    Tobimatsu M; Konomi K; Saito S; Tsumagari T
    Surgery; 1985 Jul; 98(1):45-53. PubMed ID: 4040271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphologic criteria of the efficacy of experimental therapy of acute renal failure with prostaglandin E2].
    Glants RM; Oborin AN; Kovalishin VI; Dzis' EI; Chaplik VV
    Gematol Transfuziol; 1986 Feb; 31(2):18-23. PubMed ID: 3456949
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for prostaglandin-independent mechanisms in renin release mediated by alpha adrenoceptors during renal nerve stimulation in anesthetized dogs.
    Hisa H; Takahashi K; Satoh S
    J Pharmacol Exp Ther; 1984 May; 229(2):547-50. PubMed ID: 6325667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandins activation of erythropoietin production and erythroid progenitor cells.
    Fisher JW; Radtke HW; Jubiz W; Nelson PK; Burdowski A
    Exp Hematol; 1980; 8 Suppl 8():65-89. PubMed ID: 6761139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cyclic 3'5'-adenosine monophosphate in cultured renal (MDCK) cells by endogenous prostaglandins.
    Hassid A
    J Cell Physiol; 1983 Sep; 116(3):297-302. PubMed ID: 6309869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic nephritis prevention by prostaglandins E2 and F2 alpha.
    Păuşescu E; Laki D; Popescu MV; Chiper-Stancu D
    Clin Nephrol; 1984 Mar; 21(3):169-73. PubMed ID: 6584257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correction of metabolic disorders in acute kidney failure caused by hemotransfusion, by intra-aorta administration of prostaglandin E2].
    Glants RM; Kachorovskii BV; Turchin VL; Chaplik VV; Oborin AN
    Gematol Transfuziol; 1988 Apr; 33(4):36-40. PubMed ID: 3165080
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of prostaglandin E2 on experimental mesenteric ischemia in rats].
    Fernández Alonso A; Martínez Rodríguez E; Vega Alvarez JA
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):659-65. PubMed ID: 3481448
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
    Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
    Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
    Zipser RD; Radvan GH; Kronborg IJ; Duke R; Little TE
    Gastroenterology; 1983 Apr; 84(4):697-703. PubMed ID: 6572162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the intra-aortic administration of prostaglandin E2 on kidney functions in acute kidney failure of blood transfusion origin].
    Glants RM; Kachorovskiĭ BV; Turchin VL; Oborin AN; Chaplik VV
    Biull Eksp Biol Med; 1986 Oct; 102(10):412-4. PubMed ID: 3464320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against ischemic acute renal failure by prostaglandin infusion.
    Mandal AK; Miller J
    Prostaglandins Leukot Med; 1982 Apr; 8(4):361-73. PubMed ID: 6955804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.